title: Local disruption of glial adenosine homeostasis in mice associates with focal electrographic seizures: a first step in epileptogenesis?
abstract: Astrogliosis and associated dysfunction of adenosine homeostasis are pathological hallmarks of the epileptic brain and thought to contribute to seizure generation in epilepsy. The authors hypothesized that astrogliosis-an early component of the epileptogenic cascade-might be linked to focal seizure onset. To isolate the contribution of astrogliosis to ictogenesis from other pathological events involved in epilepsy, the authors used a minimalistic model of epileptogenesis in mice, based on a focal onset status epilepticus triggered by intra-amygdaloid injection of kainic acid. The authors demonstrate acute neuronal cell loss restricted to the injected amygdala and ipsilateral CA3, followed 3 weeks later by focal astrogliosis and overexpression of the adenosine-metabolizing enzyme adenosine kinase (ADK). Using synchronous electroencephalographic recordings from multiple depth electrodes, the authors identify the KA-injected amygdala and ipsilateral CA3 as two independent foci for the initiation of non-synchronized electrographic subclinical seizures. Importantly, seizures remained focal and restricted to areas of ADK overexpression. However, after systemic application of a non-convulsive dose of an adenosine A(1) -receptor antagonist, seizures in amygdala and CA3 immediately synchronized and spread throughout the cortex, leading to convulsive seizures. This focal seizure phenotype remained stable over at least several weeks. We conclude that astrogliosis via disruption of adenosine homeostasis per se and in the absence of any other overt pathology, is associated with the emergence of spontaneous recurrent subclinical seizures, which remain stable over space and time. A secondary event, here mimicked by brain-wide disruption of adenosine signaling, is likely required to turn pre-existing subclinical seizures into a clinical seizure phenotype.
authors.affiliation: Robert S. Dow Neurobiology Laboratories, Legacy Research Institute, Portland, Oregon 97232, USA.
authors.forename: Tianfu
authors.initials: T
authors.lastname: Li
authors.forename: Nikki
authors.initials: N
authors.lastname: Lytle
authors.forename: Jing-Quan
authors.initials: JQ
authors.lastname: Lan
authors.forename: Ursula S
authors.initials: US
authors.lastname: Sandau
authors.forename: Detlev
authors.initials: D
authors.lastname: Boison
mesh_terms: D000241:Adenosine / Q000378:metabolism*; D000248:Adenosine Kinase / Q000378:metabolism; D000679:Amygdala / Q000187:drug effects / Q000473:pathology; D000818:Animals; D004195:Disease Models, Animal; D004569:Electroencephalography; D005786:Gene Expression Regulation / Q000187:drug effects; D005911:Gliosis / Q000139:chemically induced / Q000150:complications*; D006624:Hippocampus / Q000187:drug effects / Q000473:pathology; D007608:Kainic Acid / Q000633:toxicity; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009457:Neuroglia / Q000378:metabolism*; D012640:Seizures / Q000209:etiology* / Q000473:pathology*; D013997:Time Factors
chemical_list: D000248:Adenosine Kinase; D000241:Adenosine; D007608:Kainic Acid